{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:55:59Z","timestamp":1790582159002,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020771","name":"Natural Science Foundation for Young Scientists of Shanxi Province","doi-asserted-by":"publisher","award":["82300882"],"award-info":[{"award-number":["82300882"]}],"id":[{"id":"10.13039\/501100020771","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the General project, Shaanxi Science and Technology Research","award":["2022SF-103"],"award-info":[{"award-number":["2022SF-103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04791-5","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:11:27Z","timestamp":1790579487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil recovery characteristics in patients with severe antithyroid drug-induced agranulocytosis: A 12-year retrospective study"],"prefix":"10.1007","volume":"91","author":[{"given":"Yuanlin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4791_CR1","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper et al., 2016 american thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 26, 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"4791_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"P.N. Taylor, D. Albrecht, A. Scholz et al., Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301\u2013316 (2018). https:\/\/doi.org\/10.1038\/nrendo.2018.18","journal-title":"Nat. Rev. Endocrinol."},{"key":"4791_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40618-017-0626-x","volume":"40","author":"Y He","year":"2017","unstructured":"Y. He, J. Li, J. Zheng et al., Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: Retrospective analysis over 16 years at one chinese center. J. Endocrinol. Invest. 40, 733\u2013740 (2017). https:\/\/doi.org\/10.1007\/s40618-017-0626-x","journal-title":"J. Endocrinol. Invest."},{"key":"4791_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7652\/jdyxb202001021","volume":"41","author":"Y He","year":"2020","unstructured":"Y. He, W. Qiang, Y. Zhao et al., Case analysis of antithyroid drug-induced agranulocytosis combined with fatal complications. J. Xi\u2019an Jiaotong Univ. Med. Sci. 41, 114\u2013119 (2020). https:\/\/doi.org\/10.7652\/jdyxb202001021","journal-title":"J. Xi\u2019an Jiaotong Univ. Med. Sci."},{"key":"4791_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.revmed.2016.02.014","volume":"37","author":"E Andr\u00e8s","year":"2016","unstructured":"E. Andr\u00e8s, T. Weitten, R. Mourot-Cottet et al., [antithyroid agents related agranulocytosis: Literature review]. Rev. Med. Interne. 37, 544\u2013550 (2016). https:\/\/doi.org\/10.1016\/j.revmed.2016.02.014","journal-title":"Rev. Med. Interne"},{"key":"4791_CR6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bcp.13989","volume":"85","author":"WT Chen","year":"2019","unstructured":"W.T. Chen, C.C. Chi, Associations of hla genotypes with antithyroid drug-induced agranulocytosis: A systematic review and meta-analysis of pharmacogenomics studies. Br. J. Clin. Pharmacol. 85, 1878\u20131887 (2019). https:\/\/doi.org\/10.1111\/bcp.13989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4791_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/17425255.2015.985649","volume":"11","author":"A Johnston","year":"2015","unstructured":"A. Johnston, J. Uetrecht, Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin. Drug Metab. Toxicol. 11, 243\u2013257 (2015). https:\/\/doi.org\/10.1517\/17425255.2015.985649","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"4791_CR8","doi-asserted-by":"publisher","unstructured":"E. Andr\u00e8s, N. Lorenzo Villalba, R. Mourot-Cottet et al., Severe neutropenia and agranulocytosis related to antithyroid drugs: A study of 30 cases managed in a single reference center. Med. (Basel). 7 (2020). https:\/\/doi.org\/10.3390\/medicines7030015","DOI":"10.3390\/medicines7030015"},{"key":"4791_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41397-020-00187-4","volume":"21","author":"S Nakakura","year":"2021","unstructured":"S. Nakakura, K. Hosomichi, S. Uchino et al., Hla-b*39:01:01 is a novel risk factor for antithyroid drug-induced agranulocytosis in japanese population. Pharmacogenomics J. 21, 94\u2013101 (2021). https:\/\/doi.org\/10.1038\/s41397-020-00187-4","journal-title":"Pharmacogenomics J."},{"key":"4791_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/iid3.359","volume":"8","author":"X Gong","year":"2020","unstructured":"X. Gong, P. Chen, P. Ma et al., Mica polymorphisms associated with antithyroid drug-induced agranulocytosis in the chinese han population. Immun. Inflamm. Dis. 8, 695\u2013703 (2020). https:\/\/doi.org\/10.1002\/iid3.359","journal-title":"Immun. Inflamm. Dis."},{"key":"4791_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/thy.2005.15.292","volume":"15","author":"J Tajiri","year":"2005","unstructured":"J. Tajiri, S. Noguchi, Antithyroid drug-induced agranulocytosis: How has granulocyte colony-stimulating factor changed therapy? Thyroid. 15, 292\u2013297 (2005). https:\/\/doi.org\/10.1089\/thy.2005.15.292","journal-title":"Thyroid"},{"key":"4791_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/thy.2015.0439","volume":"26","author":"J Yang","year":"2016","unstructured":"J. Yang, Y.J. Zhu, J.J. Zhong et al., Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: A retrospective analysis of 114 cases in a single institution in china involving 9690 patients referred for radioiodine treatment over 15 years. Thyroid. 26, 627\u2013633 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0439","journal-title":"Thyroid"},{"key":"4791_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/jcma.0000000000000966","volume":"86","author":"C-H Tseng","year":"2023","unstructured":"C.-H. Tseng, C.-L. Tseng, H.-S. Chen et al., Clinical characteristics of neutropenic patients under antithyroid drug: Twelve-year experience in a medical center. J. Chin. Med. Association. 86, 826\u2013834 (2023). https:\/\/doi.org\/10.1097\/jcma.0000000000000966","journal-title":"J. Chin. Med. Association"},{"key":"4791_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3803\/EnM.2015.30.4.475","volume":"30","author":"HK Kim","year":"2015","unstructured":"H.K. Kim, J.H. Yoon, M.J. Jeon et al., Characteristics of korean patients with antithyroid drug-induced agranulocytosis: A multicenter study in korea. Endocrinol. Metab. (Seoul). 30, 475\u2013480 (2015). https:\/\/doi.org\/10.3803\/EnM.2015.30.4.475","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"4791_CR15","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1210\/jcem.77.5.7521347","volume":"77","author":"H Tamai","year":"1993","unstructured":"H. Tamai, T. Mukuta, S. Matsubayashi et al., Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhg-csf). J. Clin. Endocrinol. Metab. 77, 1356\u20131360 (1993). https:\/\/doi.org\/10.1210\/jcem.77.5.7521347","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4791_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","volume":"94","author":"E Andr\u00e8s","year":"2001","unstructured":"E. Andr\u00e8s, J.E. Kurtz, A.E. Perrin et al., Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. Qjm. 94, 423\u2013428 (2001). https:\/\/doi.org\/10.1093\/qjmed\/94.8.423","journal-title":"Qjm"},{"key":"4791_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/thy.1999.9.29","volume":"9","author":"S Fukata","year":"1999","unstructured":"S. Fukata, K. Kuma, M. Sugawara, Granulocyte colony-stimulating factor (g-csf) does not improve recovery from antithyroid drug-induced agranulocytosis: A prospective study. Thyroid. 9, 29\u201331 (1999). https:\/\/doi.org\/10.1089\/thy.1999.9.29","journal-title":"Thyroid"},{"key":"4791_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/archinte.153.4.509","volume":"153","author":"J Tajiri","year":"1993","unstructured":"J. Tajiri, S. Noguchi, S. Okamura et al., Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch. Intern. Med. 153, 509\u2013514 (1993). https:\/\/doi.org\/10.1001\/archinte.153.4.509","journal-title":"Arch. Intern. Med."},{"key":"4791_CR19","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1210\/jc.2011-2221","volume":"97","author":"N Watanabe","year":"2012","unstructured":"N. Watanabe, H. Narimatsu, J.Y. Noh et al., Antithyroid drug-induced hematopoietic damage: A retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with graves\u2019 disease. J. Clin. Endocrinol. Metab. 97, E49\u201353 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2221","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4791_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"D.S. Cooper, Antithyroid drugs. N Engl. J. Med. 352, 905\u2013917 (2005). https:\/\/doi.org\/10.1056\/NEJMra042972","journal-title":"N Engl. J. Med."},{"key":"4791_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40268-017-0172-1","volume":"17","author":"N Vicente","year":"2017","unstructured":"N. Vicente, L. Cardoso, L. Barros et al., Antithyroid drug-induced agranulocytosis: State of the art on diagnosis and management. Drugs R D 17, 91\u201396 (2017). https:\/\/doi.org\/10.1007\/s40268-017-0172-1","journal-title":"Drugs R D"},{"key":"4791_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejim.2006.07.012","volume":"17","author":"E Andres","year":"2006","unstructured":"E. Andres, J. Zimmer, S. Affenberger et al., Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. Eur. J. Intern. Med. 17, 529\u2013535 (2006). https:\/\/doi.org\/10.1016\/j.ejim.2006.07.012","journal-title":"Eur. J. Intern. Med."},{"key":"4791_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1507\/endocrj.ej12-0332","volume":"60","author":"J Yang","year":"2013","unstructured":"J. Yang, J. Zhong, X.H. Xiao et al., The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr. J. 60, 185\u2013189 (2013). https:\/\/doi.org\/10.1507\/endocrj.ej12-0332","journal-title":"Endocr. J."},{"key":"4791_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00000441-192610000-00005","volume":"172","author":"KRUMBHAAR","year":"1926","unstructured":"KRUMBHAAR, Leukemoid blood pictures in various clinical conditions. Am. J. Med. Sci. 172, 519\u2013532 (1926). https:\/\/doi.org\/10.1097\/00000441-192610000-00005","journal-title":"Am. J. Med. Sci."},{"key":"4791_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s13312-015-0755-2","volume":"52","author":"P Mandal","year":"2015","unstructured":"P. Mandal, S.B. Mukherjee, Leukemoid reaction\u2013a tale of 50 years. Indian Pediatr. 52, 973\u2013974 (2015). https:\/\/doi.org\/10.1007\/s13312-015-0755-2","journal-title":"Indian Pediatr."},{"key":"4791_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.46989\/001c.94105","volume":"6","author":"M Lucena","year":"2024","unstructured":"M. Lucena, K.J. Gaffney, T. Urban et al., Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia. Clin. Hematol. Int. 6, 59\u201366 (2024). https:\/\/doi.org\/10.46989\/001c.94105","journal-title":"Clin. Hematol. Int."},{"key":"4791_CR27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"D. Averbuch, C. Orasch, C. Cordonnier et al., European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th european conference on infections in leukemia. Haematologica. 98,1826\u20131835 (2013). https:\/\/doi.org\/10.3324\/haematol.2013.091025","journal-title":"Haematologica"},{"key":"4791_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08104.x","volume":"150","author":"E Andres","year":"2010","unstructured":"E. Andres, F. Maloisel, J. Zimmer, The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis. Br. J. Haematol. 150, 3\u20138 (2010). https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08104.x","journal-title":"Br. J. Haematol."},{"key":"4791_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1345\/aph.1A045","volume":"36","author":"EL Marcus","year":"2002","unstructured":"E.L. Marcus, A.M. Clarfield, Y. Kleinman et al., Agranulocytosis associated with initiation of famotidine therapy. Ann. Pharmacother. 36, 267\u2013271 (2002). https:\/\/doi.org\/10.1345\/aph.1A045","journal-title":"Ann. Pharmacother"},{"key":"4791_CR30","doi-asserted-by":"publisher","first-page":"19336","DOI":"10.1038\/s41598-023-46307-5","volume":"13","author":"F Kamitani","year":"2023","unstructured":"F. Kamitani, Y. Nishioka, M. Koizumi et al., Antithyroid drug-induced leukopenia and g-csf administration: A long-term cohort study. Sci. Rep. 13, 19336 (2023). https:\/\/doi.org\/10.1038\/s41598-023-46307-5","journal-title":"Sci. Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04791-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:11:29Z","timestamp":1790579489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04791-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4791"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04791-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The work was approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University School of Medicine (No. KYLLSL-2015-149-01, date of registration: 2015-04-21).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"315"}}